speb/financial-data huggingface dataset:
NYT cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -24817000.00
NYT cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 12512000.00
NYT balance_sheet (annual, 2024-12-31) — Net PPE: 521131000.00
NYT balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 1259507000.00
NYT balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 111397000.00
NYT balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 13230000.00
NYT balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 13230000.00
NYT balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 111397000.00
NYT balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 214641000.00
NYT income_statement (annual, 2024-12-31) — Normalized EBITDA: 487264000.00
NYT income_statement (annual, 2024-12-31) — Normalized Income: 302108600.00
NYT cash_flow (annual, 2024-12-31) — Operating Cash Flow: 410512000.00
NYT cash_flow (annual, 2024-12-31) — Operating Gains Losses: -28031000.00
NYT income_statement (annual, 2024-12-31) — Operating Income: 358916000.00
NYT income_statement (annual, 2024-12-31) — Operating Revenue: 2294518000.00
NYT balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 163768415.00
NYT balance_sheet (annual, 2024-12-31) — Other Current Assets: 71001000.00
NYT balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 187082000.00
NYT balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 187082000.00
NYT income_statement (annual, 2024-12-31) — Other Gand A: 307930000.00
NYT income_statement (annual, 2024-12-31) — Other Income Expense: -11978000.00
NYT balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 255529000.00
NYT cash_flow (annual, 2024-12-31) — Other Non Cash Items: -9369000.00
NYT balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 185201000.00
NYT balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 35615000.00
NYT income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -1178000.00
NYT balance_sheet (annual, 2024-12-31) — Other Properties: 484396000.00
NYT balance_sheet (quarterly, 2024-12-31) — Other Properties: 484396000.00
NYT balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 366474000.00
NYT income_statement (annual, 2024-12-31) — Other Special Charges: 10800000.00
NYT balance_sheet (annual, 2024-12-31) — Payables: 123606000.00
NYT balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 426447000.00
NYT cash_flow (annual, 2024-12-31) — Pension And Employee Benefit Expense: -28031000.00
NYT balance_sheet (annual, 2024-12-31) — Prepaid Assets: 49869000.00
NYT income_statement (annual, 2024-12-31) — Pretax Income: 383423000.00
NYT balance_sheet (annual, 2024-12-31) — Properties: 0.00
NYT balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
NYT cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
NYT cash_flow (annual, 2024-12-31) — Purchase Of Investment: -480017000.00
NYT balance_sheet (annual, 2024-12-31) — Receivables: 249530000.00
NYT income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 1300426000.00
NYT income_statement (annual, 2024-12-31) — Reconciled Depreciation: 92024000.00
NYT cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -85043000.00
NYT income_statement (annual, 2024-12-31) — Research And Development: 248198000.00
NYT income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
NYT balance_sheet (annual, 2024-12-31) — Retained Earnings: 2325142000.00
NYT cash_flow (annual, 2024-12-31) — Sale Of Investment: 190592000.00
NYT income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 278425000.00
NYT income_statement (annual, 2024-12-31) — Selling General And Administration: 586355000.00
NYT balance_sheet (annual, 2024-12-31) — Share Issued: 178664427.00
NYT income_statement (annual, 2024-12-31) — Special Income Charges: -10800000.00
NYT cash_flow (annual, 2024-12-31) — Stock Based Compensation: 67499000.00
NYT balance_sheet (annual, 2024-12-31) — Stockholders Equity: 1927209000.00
NYT balance_sheet (annual, 2024-12-31) — Tangible Book Value: 1259507000.00
NYT income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -2516400.00
NYT income_statement (annual, 2024-12-31) — Tax Provision: 89598000.00
NYT income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.23
NYT balance_sheet (annual, 2024-12-31) — Total Assets: 2841479000.00
NYT balance_sheet (annual, 2024-12-31) — Total Capitalization: 1927209000.00
NYT balance_sheet (annual, 2024-12-31) — Total Debt: 37255000.00
NYT balance_sheet (quarterly, 2024-12-31) — Total Debt: 37255000.00
NYT balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 1927209000.00
NYT income_statement (annual, 2024-12-31) — Total Expenses: 2227003000.00
NYT balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 914270000.00
NYT balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 1902680000.00
NYT balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 300741000.00
NYT income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 351096000.00
NYT income_statement (annual, 2024-12-31) — Total Unusual Items: -10800000.00
NYT income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -10800000.00
NYT balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 14896012.00
NYT balance_sheet (annual, 2024-12-31) — Treasury Stock: 406446000.00
NYT balance_sheet (annual, 2024-12-31) — Unrealized Gain Loss: 830000.00
NYT balance_sheet (annual, 2024-12-31) — Working Capital: 322793000.00
NYT income_statement (annual, 2024-12-31) — Write Off: 0.00
NYT income_statement (quarterly, 2025-03-31) — +Operating Expense: 233789000.00
NYT income_statement (quarterly, 2025-03-31) — +Total Revenue: 635910000.00
NYT balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 121628000.00
NYT balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 192514000.00
NYT balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -920195000.00
NYT balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 347486000.00
NYT balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -11612000.00
NYT balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 380249000.00
NYT income_statement (quarterly, 2025-03-31) — Basic Average Shares: 163779000.00
NYT income_statement (quarterly, 2025-03-31) — Basic EPS: 0.30
NYT cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 213857000.00
NYT cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -9237000.00
NYT cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -9237000.00
NYT balance_sheet (quarterly, 2025-03-31) — Capital Stock: 17943000.00
NYT balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 182597000.00
NYT balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 522074000.00
NYT cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -22069000.00
NYT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -107269000.00
NYT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -8340000.00
NYT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 99088000.00
NYT cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -92257000.00
NYT cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 32079000.00
NYT cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 7029000.00
NYT cash_flow (quarterly, 2025-03-31) — Change In Payable: -92257000.00
NYT cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -92257000.00
NYT cash_flow (quarterly, 2025-03-31) — Change In Receivables: 57016000.00
NYT cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 3867000.00
NYT cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 57016000.00
NYT cash_flow (quarterly, 2025-03-31) — Changes In Cash: -16521000.00
NYT balance_sheet (quarterly, 2025-03-31) — Common Stock: 17943000.00
NYT cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -22069000.00
NYT balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1884856000.00
NYT cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -58957000.00
NYT income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 334637000.00
NYT balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 239520000.00
NYT balance_sheet (quarterly, 2025-03-31) — Current Assets: 801574000.00
NYT balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 554853000.00
NYT cash_flow (quarterly, 2025-03-31) — Depreciation: 23707000.00
NYT cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 23707000.00
NYT income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 21378000.00
NYT cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 23707000.00
NYT income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 21378000.00
NYT income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 164908000.00
NYT income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.30
NYT income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 49551000.00
NYT income_statement (quarterly, 2025-03-31) — EBIT: 67484000.00
NYT income_statement (quarterly, 2025-03-31) — EBITDA: 91191000.00
NYT cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -178000.00
NYT balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 215478000.00
NYT cash_flow (quarterly, 2025-03-31) — End Cash Position: 197158000.00
NYT cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -107269000.00
NYT balance_sheet (quarterly, 2025-03-31) — Foreign Currency Translation Adjustments: -928000.00
NYT cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 89851000.00
NYT balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -359972000.00
NYT income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 79913000.00
NYT balance_sheet (quarterly, 2025-03-31) — Goodwill: 414795000.00
NYT balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 663521000.00
NYT balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 204126000.00
NYT balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1402924000.00
NYT income_statement (quarterly, 2025-03-31) — Gross Profit: 301273000.00
NYT income_statement (quarterly, 2025-03-31) — Interest Expense: 248000.00
NYT income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 248000.00
NYT income_statement (quarterly, 2025-03-31) — Interest Income: 9972000.00
NYT income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 9972000.00
NYT balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1884856000.00
NYT cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -8340000.00
NYT balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 380249000.00
NYT balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 380249000.00
NYT balance_sheet (quarterly, 2025-03-31) — Minimum Pension Liabilities: -360627000.00
NYT cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -58957000.00
NYT income_statement (quarterly, 2025-03-31) — Net Income: 49551000.00
NYT income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 49551000.00
NYT income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 49551000.00
NYT income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 49551000.00
NYT income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 49551000.00
NYT cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 49551000.00
NYT income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 49551000.00
NYT income_statement (quarterly, 2025-03-31) — Net Interest Income: 9972000.00
NYT cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -6334000.00
NYT income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 9972000.00
NYT cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -26243000.00
NYT cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 7231000.00
NYT balance_sheet (quarterly, 2025-03-31) — Net PPE: 482729000.00
NYT balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1221335000.00
NYT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 123038000.00
NYT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 123038000.00
NYT balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 215478000.00
NYT income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 95588000.00
NYT income_statement (quarterly, 2025-03-31) — Normalized Income: 52957011.55
NYT cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 99088000.00
NYT cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 1981000.00
NYT income_statement (quarterly, 2025-03-31) — Operating Income: 67484000.00
NYT income_statement (quarterly, 2025-03-31) — Operating Revenue: 572333000.00
NYT balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 163325569.00
NYT balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 37118000.00
NYT balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 193705000.00
NYT income_statement (quarterly, 2025-03-31) — Other Gand A: 79913000.00
NYT income_statement (quarterly, 2025-03-31) — Other Income Expense: -13488000.00
NYT balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 248726000.00
NYT cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 2629000.00
NYT balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 281477000.00
NYT balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 79878000.00
NYT income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -9091000.00
NYT balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 339477000.00
NYT income_statement (quarterly, 2025-03-31) — Other Special Charges: 4397000.00
NYT balance_sheet (quarterly, 2025-03-31) — Payables: 121628000.00
NYT balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 361148000.00
NYT cash_flow (quarterly, 2025-03-31) — Pension And Employee Benefit Expense: 1981000.00
NYT balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 49868000.00
NYT income_statement (quarterly, 2025-03-31) — Pretax Income: 63968000.00
NYT cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -168265000.00
NYT balance_sheet (quarterly, 2025-03-31) — Receivables: 192514000.00
NYT income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 332308000.00
NYT income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 23707000.00
NYT cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -58957000.00
NYT income_statement (quarterly, 2025-03-31) — Research And Development: 66539000.00
NYT balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 2345027000.00
NYT cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 161931000.00
NYT income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 65959000.00
NYT income_statement (quarterly, 2025-03-31) — Selling General And Administration: 145872000.00
NYT balance_sheet (quarterly, 2025-03-31) — Share Issued: 179401767.00
NYT income_statement (quarterly, 2025-03-31) — Special Income Charges: -4397000.00
NYT cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 17353000.00
NYT balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1884856000.00
NYT balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1221335000.00
NYT income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -990988.45
NYT income_statement (quarterly, 2025-03-31) — Tax Provision: 14417000.00
NYT income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.23
NYT balance_sheet (quarterly, 2025-03-31) — Total Assets: 2735065000.00
NYT balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1884856000.00
NYT balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1884856000.00
NYT income_statement (quarterly, 2025-03-31) — Total Expenses: 568426000.00
NYT balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 850209000.00
NYT balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1931014000.00
NYT balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 295356000.00
NYT income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 58634000.00
NYT income_statement (quarterly, 2025-03-31) — Total Unusual Items: -4397000.00
NYT income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -4397000.00
NYT balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 16076198.00
NYT balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 465628000.00
NYT balance_sheet (quarterly, 2025-03-31) — Unrealized Gain Loss: 1583000.00
NYT balance_sheet (quarterly, 2025-03-31) — Working Capital: 246721000.00
NYT income_statement (quarterly, 2025-06-30) — +Operating Expense: 237053000.00
NYT income_statement (quarterly, 2025-06-30) — +Total Revenue: 685873000.00
NYT balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 120187000.00
NYT balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 211078000.00
NYT balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -929576000.00
NYT balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 369208000.00
NYT balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -11301000.00
NYT balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 411300000.00
NYT income_statement (quarterly, 2025-06-30) — Basic Average Shares: 163331000.00
NYT income_statement (quarterly, 2025-06-30) — Basic EPS: 0.51
NYT cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 197158000.00
NYT cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -10336000.00
NYT cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -10336000.00
NYT balance_sheet (quarterly, 2025-06-30) — Capital Stock: 17959000.00
NYT balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 198242000.00
NYT balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 540245000.00
NYT cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -29601000.00
NYT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -54482000.00
NYT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -43742000.00
NYT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 113638000.00
NYT cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 16923000.00
NYT cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -2808000.00
NYT cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -2240000.00
NYT cash_flow (quarterly, 2025-06-30) — Change In Payable: 16923000.00
NYT cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 16923000.00
NYT cash_flow (quarterly, 2025-06-30) — Change In Receivables: -18564000.00
NYT cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -6689000.00
NYT cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -18564000.00
NYT cash_flow (quarterly, 2025-06-30) — Changes In Cash: 15414000.00
NYT balance_sheet (quarterly, 2025-06-30) — Common Stock: 17959000.00
NYT cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -29601000.00
NYT balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1935708000.00
NYT cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -23604000.00
NYT income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 338779000.00
NYT balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 267786000.00
NYT balance_sheet (quarterly, 2025-06-30) — Current Assets: 855002000.00
NYT balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 190012000.00
NYT balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 190012000.00
NYT balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 577985000.00
NYT cash_flow (quarterly, 2025-06-30) — Depreciation: 23732000.00
NYT cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 23732000.00
NYT income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 21396000.00
NYT cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 23732000.00
NYT income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 21396000.00
NYT income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 164346000.00
NYT income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.50
NYT income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 82945000.00
NYT income_statement (quarterly, 2025-06-30) — EBIT: 112007000.00
NYT income_statement (quarterly, 2025-06-30) — EBITDA: 135739000.00
NYT cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 385000.00
NYT balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 212312000.00
NYT cash_flow (quarterly, 2025-06-30) — End Cash Position: 212957000.00
NYT cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -54482000.00
NYT balance_sheet (quarterly, 2025-06-30) — Foreign Currency Translation Adjustments: -4504000.00
NYT cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 103302000.00
NYT balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -360181000.00
NYT income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 82552000.00
NYT balance_sheet (quarterly, 2025-06-30) — Goodwill: 409229000.00
NYT balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 652567000.00
NYT balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 222379000.00
NYT balance_sheet (quarterly, 2025-06-30) — Gross PPE: 1407525000.00
NYT income_statement (quarterly, 2025-06-30) — Gross Profit: 347094000.00
NYT income_statement (quarterly, 2025-06-30) — Interest Expense: 343000.00
NYT income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 343000.00
NYT income_statement (quarterly, 2025-06-30) — Interest Income: 10095000.00
NYT income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 10095000.00
NYT balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1935708000.00
NYT cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -43742000.00
NYT balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 411300000.00
NYT balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 411300000.00
NYT balance_sheet (quarterly, 2025-06-30) — Minimum Pension Liabilities: -357378000.00
NYT cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -23604000.00
NYT income_statement (quarterly, 2025-06-30) — Net Income: 82945000.00
NYT income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 82945000.00
NYT income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 82945000.00
NYT income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 82945000.00
NYT income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 82945000.00
NYT cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 82945000.00
NYT income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 82945000.00
NYT income_statement (quarterly, 2025-06-30) — Net Interest Income: 9752000.00
NYT cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -33721000.00
NYT income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 9752000.00
NYT cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -1277000.00
NYT cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 315000.00
NYT balance_sheet (quarterly, 2025-06-30) — Net PPE: 477949000.00
NYT balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1283141000.00
NYT balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 128113000.00
NYT balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 128113000.00
NYT balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 212312000.00
NYT income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 139229000.00
NYT income_statement (quarterly, 2025-06-30) — Normalized Income: 85538070.00
NYT cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 113638000.00
NYT cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -2591000.00
NYT income_statement (quarterly, 2025-06-30) — Operating Income: 110041000.00
NYT income_statement (quarterly, 2025-06-30) — Operating Revenue: 615394000.00
NYT balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 163016689.00
NYT balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 45717000.00
NYT income_statement (quarterly, 2025-06-30) — Other Gand A: 82552000.00
NYT income_statement (quarterly, 2025-06-30) — Other Income Expense: -8129000.00
NYT balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 243338000.00
NYT cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -1562000.00
NYT balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 280105000.00
NYT balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 79031000.00
NYT income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -4639000.00
NYT balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 342003000.00
NYT income_statement (quarterly, 2025-06-30) — Other Special Charges: 3490000.00
NYT balance_sheet (quarterly, 2025-06-30) — Payables: 120187000.00
NYT balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 387973000.00
NYT cash_flow (quarterly, 2025-06-30) — Pension And Employee Benefit Expense: -2591000.00
NYT balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 57962000.00
NYT income_statement (quarterly, 2025-06-30) — Pretax Income: 111664000.00
NYT cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -132095000.00
NYT balance_sheet (quarterly, 2025-06-30) — Receivables: 211078000.00
NYT income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 336443000.00
NYT income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 23732000.00
NYT cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -23604000.00
NYT income_statement (quarterly, 2025-06-30) — Research And Development: 63940000.00
NYT balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 2398105000.00
NYT income_statement (quarterly, 2025-06-30) — Salaries And Wages: 0.00
NYT cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 98374000.00
NYT income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 69165000.00
NYT income_statement (quarterly, 2025-06-30) — Selling General And Administration: 151717000.00
NYT balance_sheet (quarterly, 2025-06-30) — Share Issued: 179553023.00
NYT income_statement (quarterly, 2025-06-30) — Special Income Charges: -3490000.00
NYT cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 17803000.00
NYT balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1935708000.00
NYT balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1283141000.00
NYT income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -896930.00
NYT income_statement (quarterly, 2025-06-30) — Tax Provision: 28719000.00
NYT income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.26
NYT balance_sheet (quarterly, 2025-06-30) — Total Assets: 2805036000.00
NYT balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1935708000.00
NYT balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1935708000.00
NYT income_statement (quarterly, 2025-06-30) — Total Expenses: 575832000.00
NYT balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 869328000.00
NYT balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1950034000.00
NYT balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 291343000.00
NYT income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 106551000.00
NYT income_statement (quarterly, 2025-06-30) — Total Unusual Items: -3490000.00
NYT income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -3490000.00
NYT balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 16536334.00
NYT balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 489383000.00
NYT balance_sheet (quarterly, 2025-06-30) — Unrealized Gain Loss: 1701000.00
NYT balance_sheet (quarterly, 2025-06-30) — Working Capital: 277017000.00
NYT income_statement (quarterly, 2025-09-30) — +Operating Expense: 244547000.00
NYT income_statement (quarterly, 2025-09-30) — +Total Revenue: 700821000.00
NYT balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 130908000.00
NYT balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 204090000.00
NYT balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -940670000.00
NYT balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 385890000.00
NYT balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -11180000.00
NYT balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 479429000.00
NYT income_statement (quarterly, 2025-09-30) — Basic Average Shares: 163022000.00
NYT income_statement (quarterly, 2025-09-30) — Basic EPS: 0.50
NYT cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 212957000.00
NYT cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -7878000.00
NYT cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -7878000.00
NYT balance_sheet (quarterly, 2025-09-30) — Capital Stock: 17963000.00
NYT balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 249339000.00
NYT balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 617352000.00
NYT cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -29403000.00
NYT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -58974000.00
NYT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -97035000.00
NYT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 207608000.00
NYT cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 61289000.00
NYT cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 7385000.00
NYT cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 9803000.00
NYT cash_flow (quarterly, 2025-09-30) — Change In Payable: 61289000.00
NYT cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 61289000.00
NYT cash_flow (quarterly, 2025-09-30) — Change In Receivables: 6989000.00
NYT cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 85466000.00
NYT cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 6989000.00
NYT cash_flow (quarterly, 2025-09-30) — Changes In Cash: 51599000.00
NYT balance_sheet (quarterly, 2025-09-30) — Common Stock: 17963000.00
NYT cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -29403000.00
NYT balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1980252000.00
NYT cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -27319000.00
NYT income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 349075000.00
NYT balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 286641000.00
NYT balance_sheet (quarterly, 2025-09-30) — Current Assets: 938298000.00
NYT balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 197940000.00
NYT balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 197940000.00
NYT balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 615489000.00
NYT cash_flow (quarterly, 2025-09-30) — Depreciation: 23865000.00
NYT cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 23865000.00
NYT income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 21341000.00
NYT cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 23865000.00
NYT income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 21341000.00
NYT income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 164398000.00
NYT income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.50
NYT income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 81647000.00
NYT income_statement (quarterly, 2025-09-30) — EBIT: 108285000.00
NYT income_statement (quarterly, 2025-09-30) — EBITDA: 132150000.00
NYT cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -347000.00
NYT balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 208691000.00
NYT cash_flow (quarterly, 2025-09-30) — End Cash Position: 264209000.00
NYT cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -58974000.00
NYT balance_sheet (quarterly, 2025-09-30) — Foreign Currency Translation Adjustments: -4754000.00
NYT cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 199730000.00
NYT balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -356788000.00
NYT income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 76640000.00
NYT balance_sheet (quarterly, 2025-09-30) — Goodwill: 409192000.00
NYT balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 645549000.00
NYT balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 215270000.00
NYT balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1411670000.00
NYT income_statement (quarterly, 2025-09-30) — Gross Profit: 351746000.00
NYT income_statement (quarterly, 2025-09-30) — Interest Expense: 286000.00
NYT income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 286000.00
NYT income_statement (quarterly, 2025-09-30) — Interest Income: 11633000.00
NYT income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 11633000.00
NYT balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1980252000.00
NYT cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -97035000.00
NYT balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 479429000.00
NYT balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 479429000.00
NYT balance_sheet (quarterly, 2025-09-30) — Minimum Pension Liabilities: -354129000.00
NYT cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -27319000.00
NYT income_statement (quarterly, 2025-09-30) — Net Income: 81647000.00
NYT income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 81647000.00
NYT income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 81647000.00
NYT income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 81647000.00
NYT income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 81647000.00
NYT cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 81647000.00
NYT income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 81647000.00
NYT income_statement (quarterly, 2025-09-30) — Net Interest Income: 11347000.00
NYT cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -94636000.00
NYT income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 11347000.00
NYT cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -2252000.00
NYT cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 5479000.00
NYT balance_sheet (quarterly, 2025-09-30) — Net PPE: 471000000.00
NYT balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1334703000.00
NYT balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 72871000.00
NYT balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 72871000.00
NYT balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 208691000.00
NYT income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 138057000.00
NYT income_statement (quarterly, 2025-09-30) — Normalized Income: 86112692.00
NYT cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 207608000.00
NYT cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -3094000.00
NYT income_statement (quarterly, 2025-09-30) — Operating Income: 107199000.00
NYT income_statement (quarterly, 2025-09-30) — Operating Revenue: 626921000.00
NYT balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 162574675.00
NYT balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 63755000.00
NYT income_statement (quarterly, 2025-09-30) — Other Gand A: 76640000.00
NYT income_statement (quarterly, 2025-09-30) — Other Income Expense: -10547000.00
NYT balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 236357000.00
NYT cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 1217000.00
NYT balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 279979000.00
NYT balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 82694000.00
NYT income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -4640000.00
NYT balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 368013000.00
NYT income_statement (quarterly, 2025-09-30) — Other Special Charges: 2411000.00
NYT balance_sheet (quarterly, 2025-09-30) — Payables: 130908000.00
NYT balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 417549000.00
NYT cash_flow (quarterly, 2025-09-30) — Pension And Employee Benefit Expense: -3094000.00
NYT balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 53101000.00
NYT income_statement (quarterly, 2025-09-30) — Pretax Income: 107999000.00
NYT cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -173028000.00
NYT balance_sheet (quarterly, 2025-09-30) — Receivables: 204090000.00
NYT income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 346551000.00
NYT income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 23865000.00
NYT cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -27319000.00
NYT income_statement (quarterly, 2025-09-30) — Research And Development: 66989000.00
NYT balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 2450139000.00
NYT cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 78392000.00
NYT income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 79577000.00
NYT income_statement (quarterly, 2025-09-30) — Selling General And Administration: 156217000.00
NYT balance_sheet (quarterly, 2025-09-30) — Share Issued: 179593842.00
NYT income_statement (quarterly, 2025-09-30) — Special Income Charges: -5907000.00
NYT cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 18507000.00
NYT balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1980252000.00
NYT balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1334703000.00
NYT income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -1441308.00
NYT income_statement (quarterly, 2025-09-30) — Tax Provision: 26352000.00
NYT income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.24
NYT balance_sheet (quarterly, 2025-09-30) — Total Assets: 2887126000.00
NYT balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1980252000.00
NYT balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1980252000.00
NYT income_statement (quarterly, 2025-09-30) — Total Expenses: 593622000.00
NYT balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 906874000.00
NYT balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1948828000.00
NYT balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 291385000.00
NYT income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 104788000.00
NYT income_statement (quarterly, 2025-09-30) — Total Unusual Items: -5907000.00
NYT income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -5907000.00
NYT balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 17019167.00
NYT balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 516952000.00
NYT balance_sheet (quarterly, 2025-09-30) — Unrealized Gain Loss: 2095000.00
NYT balance_sheet (quarterly, 2025-09-30) — Working Capital: 322809000.00
NYT income_statement (quarterly, 2025-09-30) — Write Off: 3496000.00
NYT income_statement (annual, 2025-12-31) — +Operating Expense: 984502000.00
NYT income_statement (quarterly, 2025-12-31) — +Operating Expense: 269113000.00
NYT income_statement (annual, 2025-12-31) — +Total Revenue: 2824918000.00
NYT income_statement (quarterly, 2025-12-31) — +Total Revenue: 802314000.00
NYT balance_sheet (annual, 2025-12-31) — Accounts Payable: 135623000.00
NYT balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 135623000.00
NYT balance_sheet (annual, 2025-12-31) — Accounts Receivable: 290823000.00
NYT balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 290823000.00
NYT balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -945338000.00
NYT balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -945338000.00
NYT balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 411532000.00
NYT balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 411532000.00
NYT balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -11406000.00
NYT balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -11406000.00
NYT cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 2858000.00
NYT balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 525695000.00
NYT balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 525695000.00
NYT income_statement (annual, 2025-12-31) — Basic Average Shares: 163157000.00
NYT income_statement (quarterly, 2025-12-31) — Basic Average Shares: 162448000.00
NYT income_statement (annual, 2025-12-31) — Basic EPS: 2.11
NYT income_statement (quarterly, 2025-12-31) — Basic EPS: 0.80
NYT cash_flow (annual, 2025-12-31) — Beginning Cash Position: 213857000.00
NYT cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 264209000.00
NYT balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 744507000.00
NYT balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 744507000.00
NYT cash_flow (annual, 2025-12-31) — Capital Expenditure: -33984000.00
NYT cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -6533000.00
NYT cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -33984000.00
NYT cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -6533000.00
NYT balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 36596000.00
NYT balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 36596000.00
NYT balance_sheet (annual, 2025-12-31) — Capital Stock: 17976000.00
NYT balance_sheet (quarterly, 2025-12-31) — Capital Stock: 17976000.00
NYT balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 255445000.00
NYT balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 255445000.00
NYT balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 642157000.00
NYT balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 642157000.00
NYT cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -110363000.00
NYT cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -29290000.00
NYT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -306139000.00
NYT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -85414000.00
NYT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -221316000.00
NYT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -72199000.00
NYT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 584489000.00
NYT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 164155000.00
NYT cash_flow (annual, 2025-12-31) — Change In Account Payable: 55650000.00
NYT cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 69695000.00
NYT cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 36341000.00
NYT cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -315000.00
NYT cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 24264000.00
NYT cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 9672000.00
NYT cash_flow (annual, 2025-12-31) — Change In Payable: 55650000.00
NYT cash_flow (quarterly, 2025-12-31) — Change In Payable: 69695000.00
NYT cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 55650000.00
NYT cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 69695000.00
NYT cash_flow (annual, 2025-12-31) — Change In Receivables: -41293000.00
NYT cash_flow (quarterly, 2025-12-31) — Change In Receivables: -86734000.00
NYT cash_flow (annual, 2025-12-31) — Change In Working Capital: 74962000.00
NYT cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -7682000.00
NYT cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -41293000.00
NYT cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -86734000.00
NYT cash_flow (annual, 2025-12-31) — Changes In Cash: 57034000.00
NYT cash_flow (quarterly, 2025-12-31) — Changes In Cash: 6542000.00
NYT balance_sheet (annual, 2025-12-31) — Common Stock: 17976000.00
NYT balance_sheet (quarterly, 2025-12-31) — Common Stock: 17976000.00
NYT cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -110363000.00
NYT cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -29290000.00
NYT balance_sheet (annual, 2025-12-31) — Common Stock Equity: 2041363000.00
NYT balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 2041363000.00
NYT cash_flow (annual, 2025-12-31) — Common Stock Payments: -165341000.00
NYT cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -55461000.00
NYT balance_sheet (annual, 2025-12-31) — Construction In Progress: 12378000.00
NYT balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 12378000.00
NYT income_statement (annual, 2025-12-31) — Cost Of Revenue: 1389713000.00
NYT income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 367222000.00
NYT balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 323449000.00
NYT balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 323449000.00
NYT balance_sheet (annual, 2025-12-31) — Current Assets: 1028067000.00
NYT balance_sheet (quarterly, 2025-12-31) — Current Assets: 1028067000.00
NYT balance_sheet (annual, 2025-12-31) — Current Liabilities: 666695000.00
NYT balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 666695000.00
NYT balance_sheet (annual, 2025-12-31) — Defined Pension Benefit: 75937000.00
NYT balance_sheet (quarterly, 2025-12-31) — Defined Pension Benefit: 75937000.00
NYT cash_flow (annual, 2025-12-31) — Depreciation: 95149000.00
NYT cash_flow (quarterly, 2025-12-31) — Depreciation: 23845000.00
NYT cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 95149000.00
NYT cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 23845000.00
NYT income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 85007000.00
NYT income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 20892000.00
NYT cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 95149000.00
NYT cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 23845000.00
NYT income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 85007000.00
NYT income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 20892000.00
NYT income_statement (annual, 2025-12-31) — Diluted Average Shares: 164943000.00